U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07317648) titled 'ClearSight NextGen1 Study' on Nov. 21, 2025.
Brief Summary: A prospective, non-randomized single arm study using the investigational ClearSight NextGen (CSNG) system in adult subjects.
Study Start Date: Oct. 16, 2025
Study Type: OBSERVATIONAL
Condition:
Blood Pressure
Intervention:
DEVICE: ClearSight NextGen system
Study devices will be applied to subjects for monitoring for the duration of the procedure.
Recruitment Status: RECRUITING
Sponsor: Edwards Lifesciences
Disclaimer: Curated by HT Syndication....